- Activity pressure is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
6589
TAI
Week ended 07 Aug 2026
Weekly Investor Report
EirGenix Inc. · Healthcare · Biotechnology
Latest close
48.20 TWD
7.5%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -7.2% below the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 7.5%, after a -0.1% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
26
out of 100
Latest Close
48.20 TWD
7 Aug 2026
1W Return
7.5%
latest completed week
4W Return
-0.1%
short-term follow-through
12W Return
8.1%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 38.31% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.5%
Latest completed week; four-week move -0.1%.
Indicator stack
11/64
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.31%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -7.2% below the Trend Line and sits at 18.2% of its 52-week range. The latest completed week returned 7.5%, after a -0.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.6x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0612-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.1% over four weeks, 8.1% over 12 weeks, and -23.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.41Latest activity-pressure read.
Pressure change78.9%Four-week change in activity pressure.
Leadership-41.82Latest relative-leadership reading.
RS change11.0%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-42.8%Distance below the 52-week high.
13-week volatility4.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+7.8%Week of 3 Jul.
Worst week-9.9%Week of 24 Apr.
Latest week+7.5%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains7
Flat weeks0
Modest losses11
Sharp losses5
Recent vol4.3%13-week weekly-return volatility.
Base vol5.4%52-week weekly-return volatility.
Up/down split19/33Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -3.2%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank21 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank6 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape22/100
Trend, activity pressure, participation, and risk combine to a 22/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 38.31%Next-week expectancy is negative with a 38.31% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 48.20 TWD | 7.5% | 51.95 TWD | 75.71 TWD | 0.41 | -41.82 | 3.2M | Off |
| 31 Jul 2026 | 44.85 TWD | -1.6% | 52.41 TWD | 76.08 TWD | 0.37 | -45.37 | 3.1M | Off |
| 24 Jul 2026 | 45.60 TWD | 1.7% | 53.00 TWD | 76.48 TWD | 0.52 | -46.15 | 2.0M | Off |
| 17 Jul 2026 | 44.85 TWD | -7.0% | 53.59 TWD | 76.88 TWD | 0.44 | -46.76 | 5.5M | Off |
| 10 Jul 2026 | 48.25 TWD | -2.9% | 54.34 TWD | 77.29 TWD | 0.23 | -46.99 | 5.5M | Off |
| 3 Jul 2026 | 49.70 TWD | 7.8% | 55.24 TWD | 77.70 TWD | -0.21 | -47.91 | 9.2M | Off |
| 26 Jun 2026 | 46.10 TWD | -0.8% | 56.07 TWD | 78.07 TWD | -0.82 | -50.10 | 5.5M | Off |
| 19 Jun 2026 | 46.45 TWD | 3.6% | 56.94 TWD | 78.48 TWD | -1.24 | -52.62 | 3.7M | Off |
| 12 Jun 2026 | 44.85 TWD | 1.1% | 58.12 TWD | 78.88 TWD | -1.53 | -52.65 | 5.7M | Off |
| 5 Jun 2026 | 44.35 TWD | 5.2% | 58.87 TWD | 79.31 TWD | -1.67 | -54.90 | 6.2M | Off |
| 29 May 2026 | 42.15 TWD | -3.5% | 59.62 TWD | 79.73 TWD | -1.80 | -57.55 | 12.5M | Off |
| 22 May 2026 | 43.70 TWD | -2.0% | 60.52 TWD | 80.17 TWD | -1.84 | -54.21 | 7.8M | Off |
| 15 May 2026 | 44.60 TWD | -1.7% | 61.41 TWD | 80.62 TWD | -1.85 | -52.77 | 6.0M | Off |
| 8 May 2026 | 45.35 TWD | 0.4% | 62.30 TWD | 81.16 TWD | -1.81 | -53.21 | 3.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.